Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M John Rogers

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Parasitology Today (Personal Ed.)|March 1, 1996
Rare codon usage in Escherichia coli and the expression of potentially toxic genesM John Rogers
Nature|September 6, 2002
Shared knowledge can combat malariaYimin Wu, M John Rogers
Antimicrobial Agents and Chemotherapy|November 9, 2016
Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic AgentEdmund V Capparelli, Robin Bricker-Ford, M John Rogers, et al.
Journal of Medicinal Chemistry|October 4, 2002
Parallel synthesis of potent, pyrazole-based inhibitors of Helicobacter pylori dihydroorotate dehydrogenaseTasir S Haque, Seifu Tadesse, Jovita Marcinkeviciene, et al.
Science Translational Medicine|July 17, 2015
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaMargaret A Phillips, Julie Lotharius, Kennan Marsh, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Parasitology Today (Personal Ed.)|March 1, 1996
Rare codon usage in Escherichia coli and the expression of potentially toxic genesM John Rogers
Nature|September 6, 2002
Shared knowledge can combat malariaYimin Wu, M John Rogers
Antimicrobial Agents and Chemotherapy|November 9, 2016
Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic AgentEdmund V Capparelli, Robin Bricker-Ford, M John Rogers, et al.
Journal of Medicinal Chemistry|October 4, 2002
Parallel synthesis of potent, pyrazole-based inhibitors of Helicobacter pylori dihydroorotate dehydrogenaseTasir S Haque, Seifu Tadesse, Jovita Marcinkeviciene, et al.
Science Translational Medicine|July 17, 2015
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaMargaret A Phillips, Julie Lotharius, Kennan Marsh, et al.
Pageof 1